Passage Bio Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Passage Bio Inc had 33.34M in cash and cash equivalents.

Passage Bio Inc reported 43.53M in total liabilities as of the latest reported quarter, including 23.08M in current liabilities and 20.44M in non-current liabilities.

As of the latest reported quarter, Passage Bio Inc's total assets were 62.28M, consisting of 47.76M in current assets and 14.52M in non-current assets.

Passage Bio Inc reported 18.75M in total shareholders' equity as of the latest reported quarter.